Baidu
map

Advanced Non-Small Cell Lung Cancer Patients With Low Tumor Mutation Burden Might Derive Benefit From Immunotherapy

Nie, W; Xu, MD; Gan, L; Zhang, Y; Qian, J; Gu, K; Zhang, XY; Wang, HM; Yan, B; Gu, P; Zhang, B; Wang, SY; Hu, F; Li, CH; Zhong, H; Han, BH

Han, BH (corresponding author), Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai 200030, Peoples R China.

JOURNAL OF IMMUNOTHERAPY, 2020; 43 (6): 189

Abstract

The aim of this study is to investigate the association between tumor mutation burden (TMB) and survival in non-small cell lung cancer (NSCLC) patient......

Full Text Link


Baidu
map
Baidu
map
Baidu
map